Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Aureonitol

  • Zoom
    Aureonitol
  • Aureonitol
Cat No: 32925
Cayman

Aureonitol is a fungal metabolite that has been found in Chaetomium and has antiviral activity.{54796} It inhibits replication of the influenza A subtype H3N2 with an EC50 value of 30 nM at a multiplicity of infection (MOI) of 0.01. It also inhibits r...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • (2S,3R,4S)-2-(1,3-butadien-1-yl)tetrahydro-4-(1,3-pentadien-1-yl)-3-furanol
Correlated keywords:
  • anti-viral H3-N2 H1-N1
Product Overview:
Aureonitol is a fungal metabolite that has been found in Chaetomium and has antiviral activity.{54796} It inhibits replication of the influenza A subtype H3N2 with an EC50 value of 30 nM at a multiplicity of infection (MOI) of 0.01. It also inhibits replication of laboratory-adapted and clinical isolates of H3N2 (EC50s = 100 and 312 nM, respectively), as well as clinical isolates of the influenza A subtype H1N1 (EC50 = 417 nM). Aureonitol inhibits hemagglutination activity of H3N2 and H1N1.
Size 100 µg
Shipping dry ice
CAS Number 71774-51-1
Molecular Formula C13H18O2
SMILES C/C=C/C=C/[C@H]1CO[C@@H](/C=C/C=C)[C@@H]1O
Molecular Weight 206,3
Formulation A solid
Purity ≥95%
Custom Code 2932.19
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search